A Mathematical Model of the Cell Cycle: Exploring the Impact of Zingerone on Cancer Cell Proliferation
Roumen Anguelov, Micaela Goddard, Yvette Hlophe, Kganya Letsoalo, June, Serem

TL;DR
This paper develops a mathematical model of the cell cycle focusing on CDK1-APC interactions, analyzing how Zingerone influences cancer cell proliferation and oscillatory dynamics for potential therapeutic benefits.
Contribution
It introduces a novel dynamical system model of the CDK1-APC network and investigates Zingerone's effect on cell cycle oscillations and proliferation.
Findings
Zingerone modulates the period of cell cycle oscillations.
The model predicts Zingerone's potential to inhibit cancer cell proliferation.
Experimental validation supports the theoretical predictions.
Abstract
This paper presents a mathematical model that explores the interactions between Cyclin-Dependent Kinase 1 (CDK1) and the Anaphase-Promoting Complex (APC) in cancer cells. Through the analysis of a dynamical system simulating the CDK1-APC network, we investigate the system's behavior and its implications for cancer progression and potential therapeutic interventions. Our findings highlight the critical role of CDK1-APC interactions in regulating the cell cycle and examine the impact of Zingerone, a compound derived from ginger, on modulating the period of the oscillatory dynamics. These results provide new insights into the potential of Zingerone to influence cell proliferation and offer avenues for less harmful cancer treatments. The quantitative analysis is conducted by first theoretically deriving the cell viability as a function of time and Zingerone concentration, and then…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGinger and Zingiberaceae research · Cancer-related Molecular Pathways · Immune cells in cancer
